Renal Division, The Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Diabetes Obes Metab. 2012 Aug;14(8):689-93. doi: 10.1111/j.1463-1326.2012.01562.x. Epub 2012 Feb 8.
Despite significant improvements in the treatment of diabetic nephropathy over the last 20 years, patients with type 1 diabetes are at high risk of developing end-stage renal disease (ESRD) and high mortality once ESRD develops. The timing of dialysis initiation has occurred earlier over the years, but a recent study has led to a re-evaluation of that approach. People with type 1 diabetes treated with pre-dialysis (pre-emptive) transplantation have a lower death rate than people with type 1 diabetes treated with dialysis. Living donor kidney transplantation is possible before starting dialysis and is associated with better kidney and patient outcomes as compared to transplantation while on dialysis. Multiple barriers remain that prevent people with type 1 diabetes from enjoying the reduced risk of death afforded by a pre-emptive kidney transplant, including lack of knowledge by primary care physicians, endocrinologists and nephrologists, late referral for transplantation, patient and family misconceptions about timing of transplantation and who can be a donor. New data on both the optimal time to initiate dialysis or to pursue transplantation will be reviewed.
尽管在过去的 20 年中,糖尿病肾病的治疗取得了重大进展,但 1 型糖尿病患者仍面临发生终末期肾病(ESRD)和一旦发生 ESRD 后死亡率高的风险。近年来,透析开始的时间提前了,但最近的一项研究导致对这种方法进行了重新评估。与接受透析治疗的 1 型糖尿病患者相比,接受透析前(先发制人)移植治疗的 1 型糖尿病患者死亡率更低。在开始透析之前,可以进行活体供肾移植,与透析时进行移植相比,其肾脏和患者的预后更好。尽管有多种障碍仍然存在,阻止 1 型糖尿病患者享受先发制人肾移植带来的死亡风险降低,但包括初级保健医生、内分泌科医生和肾病科医生知识的缺乏、移植的延迟转诊、患者和家属对移植时机和谁可以成为供体的误解。将审查有关开始透析或进行移植的最佳时间的新数据。